Production and Characterization of Poly(I):poly(C)-induced Rat Interferons in Vitro
Overview
Molecular Biology
Authors
Affiliations
The synthetic polyribonucleotide polyinosinate:polycytidylate [poly(I):poly(C)] was used to induce interferon (IFN) production in a rat leiomyosarcoma cell line. Three separate IFN species were distinguished by antiviral activity on homologous and heterologous cells, interaction with Blue Sepharose CL-6B chromatography matrix, and antibody neutralization studies. Two IFN species, one with a weakly ionic and the other with a hydrophobic interaction with Blue Sepharose, exhibited heterologous antiviral activity, and were acid- and heat-labile. Both had a molecular weight of 30,000 daltons by HPLC-based molecular exclusion chromatography. The weakly ionic species was neutralized only by antiserum to L-cell IFN, whereas the hydrophobic species was neutralized by antiserum to L-cell IFN and antiserum to human leukocyte IFN. The remaining IFN species, with a weakly ionic interaction with Blue Sepharose, was acid- and heat-stable, exhibited no heterologous cell antiviral activity, and was not neutralized by any antisera to IFN. This species had a molecular weight of 39,000 daltons by HPLC-based molecular exclusion chromatography and 34,000 daltons by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. These rat fibroblast IFNs possess greater heterogeneity than that reported or observed for murine or human fibroblast IFNs. These IFNs could thus be classified as follows: one species of rat IFN-beta and two different species of unique acid-labile rat IFNs.
Sales Conniff A, Encalada G, Patel S, Bhandary M, Al-Takrouri F, Heller L RNA Biol. 2022; 19(1):841-851.
PMID: 35737804 PMC: 9235898. DOI: 10.1080/15476286.2022.2084861.
Uchide N, Ohyama K, Bessho T, Takeichi M, Toyoda H Mediators Inflamm. 2012; 2012:270670.
PMID: 22899878 PMC: 3415106. DOI: 10.1155/2012/270670.
Uchide N, Toyoda H Gene Regul Syst Bio. 2009; 1:295-302.
PMID: 19936095 PMC: 2759142. DOI: 10.4137/grsb.s374.
Gaspari A, Fleisher T, Kraemer K J Clin Invest. 1993; 92(3):1135-42.
PMID: 7690772 PMC: 288250. DOI: 10.1172/JCI116682.